We are live on ! Find out more
DRTX

DURATA THERAPEUTICS INC COM STK (DE)
DRTX

Delisted

DRTX was delisted on the 17th of November, 2014.

Back to rankings

70 hedge funds and large institutions have $172M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 11

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 74 → 70 (-4)

25% less capital invested

Capital invested by funds: $229M → $172M (-$57.3M)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

81% less call options, than puts

Call options by funds: $1.13M | Put options by funds: $5.88M

Holders
70
Holders Change
-4
Holders Change %
-5.41%
% of All Funds
2.03%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
30
Reduced
11
Closed
15
Calls
$1.13M
Puts
$5.88M
Net Calls
-$4.75M
Net Calls Change
-$1.6M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.76M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$914K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$813K
4
AIG
American International Group
New York
+$614K
5
GF
Gabelli Funds
New York
+$582K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.13M
2
Jane Street
Jane Street
New York
-$1.13M
3
Morgan Stanley
Morgan Stanley
New York
-$761K
4
SIM
Spark Investment Management
New York
-$671K
5
Millennium Management
Millennium Management
New York
-$646K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aisling Capital
New York
$25.7M – – –
Wellington Management Group
2
Wellington Management Group
Massachusetts
$25.4M +$914K +61,173 +3%
CPV
3
Canaan Partners VII
Connecticut
$24.1M – – –
O
4
OrbiMed
New York
$22.6M – – –
O
5
OppenheimerFunds
New York
$12.7M – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$10.8M +$1.76M +118,077 +16%
GIM
7
Granahan Investment Management
Massachusetts
$8.77M -$20.3K -1,356 -0.2%
Vanguard Group
8
Vanguard Group
Pennsylvania
$4.76M +$813K +54,437 +17%
BFA
9
BlackRock Fund Advisors
California
$4.75M -$96.2K -6,442 -2%
EI
10
EAM Investors
California
$2.38M – – –
State Street
11
State Street
Massachusetts
$2.27M +$22.7K +1,517 +0.9%
Northern Trust
12
Northern Trust
Illinois
$2.05M +$206K +13,765 +9%
Allianz Asset Management
13
Allianz Asset Management
Germany
$1.98M -$156K -10,455 -6%
BIT
14
BlackRock Institutional Trust
California
$1.9M -$635K -42,531 -22%
MSA
15
Mason Street Advisors
Wisconsin
$1.88M +$146K +9,743 +7%
USAA
16
United Services Automobile Association
Texas
$1.69M – – –
AIG
17
American International Group
New York
$1.21M +$614K +41,088 +75%
Bank of America
18
Bank of America
North Carolina
$1.18M +$474K +31,756 +52%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$1.13M +$255K +17,093 +24%
BCM
20
Bridgeway Capital Management
Texas
$966K – – –
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$917K +$206K +13,794 +24%
GF
22
Gabelli Funds
New York
$900K +$582K +39,000 +122%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$855K -$508 -34 -0.1%
Geode Capital Management
24
Geode Capital Management
Massachusetts
$796K +$53.4K +3,575 +6%
PP
25
PDT Partners
New York
$778K +$146K +9,775 +19%
1
2 3 4

DRTX Hedge Fund Activity: Q3 2014 in Review

70 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q3 2014, worth a combined $172M — down 25% from $229M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of DRTX and 11 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 30 added.

The largest buyer was Fidelity Investments, adding an estimated $1.76M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $1.13M sold.

  • 70 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q3 2014, down from 74 in Q2 2014.
  • Funds reported $172M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q3 2014, down 25% quarter-over-quarter.
  • 11 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q3 2014 and 15 closed out, a net change of -4 holders.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q3 2014 was Fidelity Investments, an estimated $1.76M added.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q3 2014 was Renaissance Technologies, an estimated $1.13M sold.

Based on aggregated 13F filings for Q3 2014.